Recombinant adeno-associated virus as well as construction method and application thereof
A virus and application method technology, applied in the field of genetic engineering, can solve the problems of poor specificity and unsatisfactory treatment effect of tumor immunotherapy, and achieve high DC antigen presentation efficiency, high antigen presentation ability, and long antigen sensitization time. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] Example 1 Construction of recombinant adeno-associated virus
[0043] The recombinant adeno-associated virus constructed in this example is a recombinant adeno-associated virus formed by inserting tumor antigen genes into the shuttle expression vector pAAV-MCS.
[0044] The construction steps of the recombinant adeno-associated virus are as follows:
[0045] (1) Insert the tumor antigen gene into the shuttle expression vector pAAV-MCS, so that the tumor antigen gene enters the vector containing ITR to form a recombinant plasmid;
[0046] (2) Mass extraction of the recombinant plasmid described in step 1), co-transfect AAV-293 cells with pHelper and pAAV-RC plasmids by calcium phosphate precipitation method, culture for 2-3 days, collect the culture medium and cells, use The crude virus solution was collected by repeated freezing and thawing methods.
[0047] As an alternative implementation of this embodiment, the construction steps of the recombinant adeno-associated virus can ...
Embodiment 2
[0052] The application method of the recombinant adeno-associated virus described in Example 2:
[0053] In this example, the recombinant adeno-associated virus prepared in Example 1 was used to infect DC cells with the recombinant adeno-associated virus, and the tumor-associated antigen protein was expressed in the DC cells.
[0054] As a preferred embodiment of the present invention, the application method of the recombinant adeno-associated virus further includes the following step (2): Silencing the PD-1 gene by siRNA interference, and blocking the PD-1 / PD-L1 signal.
Embodiment 3
[0055] Example 3 PD-1 gene siRNA sequence design and virus preparation:
[0056] The specific methods for silencing PD-1 gene and blocking PD-1 / PD-L1 signal by siRNA interference are as follows:
[0057] a) According to the design principles of siRNA, according to the PD-1mRNA nucleotide sequence reported in GeneBank, two online design softwares of WMG and Qigen are used to design three pairs of siRNA against PD-1mRNA. The target sequence of siRNA is as follows:
[0058]
[0059]
[0060] The sequence was screened by Gene Blast, which confirmed that there is no homology with human gene exons. SiRNA-1 having the sequence structure shown in SEQIDNo.1, siRNA-2 having the sequence structure shown in SEQIDNo.2, and siRNA-3 having the sequence structure shown in SEQIDNo.3, the above three pairs are directed to PD-1 mRNA SiRNA targets, synthesize hairpin-like template DNA with paired siRNA at both ends, connected by a loop of 6 deoxynucleotides in the middle, add stop signal polyT at the 3...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com